Market Overview:
The global haloperidol market is expected to register a CAGR of 5.5% during the forecast period, 2018-2030. The growth in the market can be attributed to factors such as rising prevalence of mental diseases, increasing demand for injectable formulations and growing geriatric population. However, high cost of treatment and side effects associated with haloperidol are some factors that are likely to restrain the growth of this market during the forecast period. Based on type, the global haloperidol market is segmented into oral and injection segments. The oral segment is expected to account for a larger share in terms of revenue in 2018 as compared to the injection segment; however, due to higher adoption rates for injectable formulations over oral ones owing to their better efficacy profiles and ease-of-use, this segment is projected grow at a higher CAGR than that of oral drugs during the forecast period.
Product Definition:
Haloperidol is a medication that is used to treat psychotic disorders such as schizophrenia. It works by blocking certain receptors in the brain that are responsible for causing psychosis.
Oral:
Oral is a route of drug administration which includes tablets, capsules, syrups or liquids. It's the most common and popular way to administer drugs globally. Drug products that are administered through oral route have first pass effect on brain hence it has more effect than injectable drugs. The factors that propel the growth of this segment include easy product availability and wide acceptance among patients as well as physicians in comparison with other routes of drug administration like injectable or transdermal patches etc.
Injection:
Injection is a form of drug delivery that involves the administration of drugs into the body. The most common way to administer drugs is by injection. Inhalation, oral and topical are other forms of drug delivery but they are less popular than injection methods.
The method allows for precise dosing at a faster rate and has greater convenience due to its ease in use, which makes it more preferable among patients as well as healthcare professionals.
Application Insights:
Mental disease segment led the global haloperidol market in 2017 and is expected to continue leading over the forecast period. The growing prevalence of mental disorders, such as major depressive disorder, bipolar disorder and schizophrenia along with rising awareness about treatment options are some of the key factors driving this segment.
The Others application segment includes cardiovascular diseases, skin infections and diabetes mellitus. Increasing incidences of these conditions are expected to drive this segment over the forecast period owing to rising geriatric population across the globe which is highly susceptible to Cardiovascular Diseases (CVDs).
Regional Analysis:
North America dominated the global haloperidol market in 2017. The presence of major players, favorable reimbursement scenario, and high awareness levels are some of the factors responsible for its largest share. In addition, increasing prevalence of mental disorders is expected to drive demand for haloperidol in this region over the forecast period.
Asia Pacific is anticipated to witness lucrative growth during the forecast period owing to rising disposable income and improving healthcare infrastructure coupled with growing pharmaceutical industry in emerging countries such as China and India. Furthermore, increasing incidence rate of schizophrenia is also likely to boost product demand during the estimated time span (2018-2030).
Growth Factors:
- Increasing prevalence of psychiatric disorders: The global prevalence of psychiatric disorders is increasing at an alarming rate. This is expected to drive the demand for haloperidol in the coming years.
- Growing awareness about mental health: There is a growing awareness about mental health and its treatment options among people across the world. This is likely to increase the demand for haloperidol in the near future.
- Rising number of geriatric population: The number of geriatric population is increasing rapidly across the globe, which will lead to an increase in demand for haloperidol for treating various neuropsychiatric conditions in this population segment.
- Technological advancements: There have been several technological advancements in drug delivery systems that are likely to benefit the growth ofhaloperidol marketin future years.. These advancements are expected to make it easier and more convenient for patients to take this medication, thereby driving its uptake globally.. 5) Availabilityof generic versions: Generic versions ofhaloperidolis available at a fractionofthe costof branded formulations, making it more affordablefor a larger sectionofthe population
Scope Of The Report
Report Attributes
Report Details
Report Title
Haloperidol Market Research Report
By Type
Oral, Injection
By Application
Mental Disease, Others
By Companies
Sandoz, Mylan, Teva, Fresenius Kabi, Gland Pharma, Zydus, Sandoz
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
196
Number of Tables & Figures
138
Customization Available
Yes, the report can be customized as per your need.
Global Haloperidol Market Report Segments:
The global Haloperidol market is segmented on the basis of:
Types
Oral, Injection
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Mental Disease, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Sandoz
- Mylan
- Teva
- Fresenius Kabi
- Gland Pharma
- Zydus
- Sandoz
Highlights of The Haloperidol Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Oral
- Injection
- By Application:
- Mental Disease
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Haloperidol Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Haloperidol is a medication used to treat schizophrenia and bipolar disorder. It works by reducing the activity of certain chemicals in the brain. Haloperidol may also be used to reduce anxiety or agitation.
Some of the key players operating in the haloperidol market are Sandoz, Mylan, Teva, Fresenius Kabi, Gland Pharma, Zydus, Sandoz.
The haloperidol market is expected to register a CAGR of 5.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Haloperidol Market Overview 4.1 Introduction 4.1.1 Market Taxonomy 4.1.2 Market Definition 4.1.3 Macro-Economic Factors Impacting the Market Growth 4.2 Haloperidol Market Dynamics 4.2.1 Market Drivers 4.2.2 Market Restraints 4.2.3 Market Opportunity 4.3 Haloperidol Market - Supply Chain Analysis 4.3.1 List of Key Suppliers 4.3.2 List of Key Distributors 4.3.3 List of Key Consumers 4.4 Key Forces Shaping the Haloperidol Market 4.4.1 Bargaining Power of Suppliers 4.4.2 Bargaining Power of Buyers 4.4.3 Threat of Substitution 4.4.4 Threat of New Entrants 4.4.5 Competitive Rivalry 4.5 Global Haloperidol Market Size & Forecast, 2020-2028 4.5.1 Haloperidol Market Size and Y-o-Y Growth 4.5.2 Haloperidol Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Oral
5.2.2 Injection
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Mental Disease
6.2.2 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Haloperidol Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Haloperidol Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Oral
9.6.2 Injection
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Mental Disease
9.10.2 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Oral
10.6.2 Injection
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Mental Disease
10.10.2 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Oral
11.6.2 Injection
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Mental Disease
11.10.2 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Oral
12.6.2 Injection
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Mental Disease
12.10.2 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Oral
13.6.2 Injection
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Mental Disease
13.10.2 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Haloperidol Market: Competitive Dashboard
14.2 Global Haloperidol Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Sandoz
14.3.2 Mylan
14.3.3 Teva
14.3.4 Fresenius Kabi
14.3.5 Gland Pharma
14.3.6 Zydus
14.3.7 Sandoz